New OpenBind consortium to make the UK a leader in AI-driven drug discovery - slashing the cost of drug discovery and development...
Drug
Over the past few years, the biotech industry has endured a long winter. Investor enthusiasm has cooled, valuations have dropped...
Regeneron Pharmaceuticals recently entered a licensing agreement with Telesis Bio Inc. to implement the Gibson SOLA™ platform, aiming to boost...
The landscape of drug discovery is evolving rapidly, driven by breakthroughs in AI, high-throughput screening and precision medicine. As researchers...
The vast majority of hormones were identified, had their biological activity defined, and were synthesized in the first half of...
